Non-muscle invasive bladder cancer (nmibc)

Clinical trials for Non-muscle invasive bladder cancer (nmibc) explained in plain language.

Never miss a new study

Get alerted when new Non-muscle invasive bladder cancer (nmibc) trials appear

Sign up with your email to follow new studies for Non-muscle invasive bladder cancer (nmibc), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 8 Not yet recruiting 8 Not yet finished but already full! 1

Combining two drugs may tackle bladder cancer that resists standard therapy

Disease control Ongoing

This trial investigates whether combining two drugs—BCG and gemcitabine—can safely and effectively treat a type of bladder cancer called non-muscle invasive bladder cancer (NMIBC) that has come back after previous BCG treatment. Participants receive BCG directly into the bladder …

Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)

Phase 1/2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Aug 13, 2026 00:00 UTC

Non-muscle invasive bladder cancer (nmibc)

Get alerted when new Non-muscle invasive bladder cancer (nmibc) trials appear

Combining two drugs may tackle bladder cancer that resists standard therapy